INSYS Therapeutics Inc. (NASDAQ:INSY) and Sierra Oncology Inc. (NASDAQ:SRRA) compete with each other in the Biotechnology sector. We will analyze and compare their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation.
Table 1 shows gross revenue, earnings per share and valuation of the two companies.
Table 2 shows INSYS Therapeutics Inc. and Sierra Oncology Inc.’s return on assets, net margins and return on equity.
Volatility and Risk
INSYS Therapeutics Inc.’s volatility measures that it’s 156.00% more volatile than Standard and Poor’s 500 due to its 2.56 beta. Sierra Oncology Inc.’s 1.77 beta is the reason why it is 77.00% more volatile than Standard and Poor’s 500.
0.7 and 0.6 are the respective Current Ratio and a Quick Ratio of INSYS Therapeutics Inc. Its rival Sierra Oncology Inc.’s Current and Quick Ratios are 14.7 and 14.7 respectively. Sierra Oncology Inc. has